Related Experiment Video
Updated: Mar 16, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis
Louise Ekholm1, J Michelle Kahlenberg2, Sevim Barbasso Helmers3
1Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Solna, Sweden louise.ekholm@karolinska.se.
Objective:
Alterations in phenotype and function of endothelial progenitor cells (EPCs) have been associated with poor vascular outcomes and impaired vascular repair in various conditions. Our hypothesis was that patients with PM and DM have dysregulation of EPCs driven by type I IFN and IL-18 similar to other autoimmune diseases.
Methods:
Quantification of circulating EPCs was performed by flow cytometry in patients with PM/DM and matched healthy controls. The ability of EPCs to differentiate into mature endothelial cells was investigated by light and fluorescence microscopy quantification in the presence or absence of PM/DM or control serum, neutralizing antibodies to type I IFN receptor or IL-18. Serum type I IFN activity was quantified by induction of type I IFN-inducible genes in HeLa cells. Circulating IL-18 concentrations were assessed by ELISA.
Results:
Circulating EPCs were significantly lower in PM/DM patients compared with controls. PM/DM EPCs displayed a decreased capacity to differentiate into mature endothelial cells and PM/DM serum significantly inhibited differentiation of control EPCs. This effect was reversed in the majority of samples with neutralizing antibodies to IL-18 or to type I IFN receptor or by a combination of these antibodies. Patients with associated impairments in EPC function had higher type I IFN serum activity.
Conclusion:
PM/DM is associated with dysregulation of EPC phenotype and function that may be attributed, at least in part, to aberrant IL-18 and type I IFN pathways. The implication of these vasculopathic findings for disease prognosis and complications remains to be determined.
Insights
Polymyositis and dermatomyositis (PM/DM) patients have fewer endothelial progenitor cells (EPCs) with impaired function. Type I interferon and IL-18 pathways contribute to this dysregulation, impacting vascular health.
Area of Science:
- Immunology
- Vascular Biology
- Rheumatology
Background:
- Endothelial progenitor cell (EPC) dysfunction is linked to poor vascular outcomes.
- Polymyositis and dermatomyositis (PM/DM) are autoimmune conditions affecting muscles and skin.
Purpose of the Study:
- To investigate EPC dysregulation in PM/DM patients.
- To determine the role of type I interferon (IFN) and IL-18 in PM/DM-associated EPC dysfunction.
Main Methods:
- Flow cytometry quantified circulating EPCs in PM/DM patients and controls.
- EPC differentiation capacity was assessed with and without PM/DM serum and neutralizing antibodies.
- Serum type I IFN activity and IL-18 concentrations were measured.
Main Results:
- PM/DM patients had significantly lower circulating EPCs compared to controls.
- PM/DM EPCs showed reduced differentiation capacity, inhibited by PM/DM serum.
- Neutralizing antibodies to IL-18 or type I IFN receptor partially reversed these effects.
Conclusions:
- PM/DM is associated with impaired EPC phenotype and function.
- Aberrant IL-18 and type I IFN pathways likely contribute to EPC dysregulation in PM/DM.
- Further research is needed to determine the clinical implications for vasculopathy.
Related Concept Videos
Myocarditis I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Differentiation of Common Myeloid Progenitor Cells
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

